Latest / Ageless and Timeless Podcast® / Peptides, Bioregulators, and the Future of Medicine with Dr. Kent Holtorf

Transcript

Peptides, Bioregulators, and the Future of Medicine with Dr. Kent Holtorf · Ageless and Timeless Podcast®

• 0:10
  Speaker 1: Good afternoon everyone. This is Michelle Hughes from Ageless and Timeless. Today,
• 0:14
  Speaker 1: I have a wonderful guest named doctor Kent Holtoor and
• 0:18
  Speaker 1: I've known Kent and his lovely wife Lorie. We've met
• 0:22
  Speaker 1: at a couple of the health and wellness shows I
• 0:27
  Speaker 1: gave for him and rad Fest and so they have
• 0:30
  Speaker 1: a company that is called Integrative pep Tides and Kent
• 0:37
  Speaker 1: welcome to Ageless and Timeless And just wanted to be
• 0:41
  Speaker 1: sure that we say the right thing.
• 0:42
  Speaker 2: But are you the founder and CEO?
• 0:46
  Speaker 3: Yeah, yeah, I'm the founder. No longer CEO stepped down
• 0:50
  Speaker 3: from that, okay, but uh yeah, It's been so wonderful
• 0:55
  Speaker 3: that I've seen you for so long at all these
• 0:58
  Speaker 3: you know, amazing conferences down and so I thank you
• 1:02
  Speaker 3: so much for having me.
• 1:03
  Speaker 1: Well not only that, but I've been using your products
• 1:06
  Speaker 1: for two years now, so I could be a great
• 1:08
  Speaker 1: spokesperson and I will.
• 1:10
  Speaker 3: Be today, But I did not know that, thank you.
• 1:12
  Speaker 1: Oh yeah, Laurie took good care of me. She got
• 1:16
  Speaker 1: me off stocked up, and I that I even have
• 1:20
  Speaker 1: the one that you're supposed to put on every day
• 1:22
  Speaker 1: for the pets.
• 1:24
  Speaker 2: But you're not a pet but Laurie said, you can
• 1:26
  Speaker 2: use it.
• 1:27
  Speaker 3: As Oh yeah, so our pet tides. Yeah, and people
• 1:31
  Speaker 3: using their pets and then found that it's a wonderful
• 1:34
  Speaker 3: face of facial cream.
• 1:36
  Speaker 2: Oh that I didn't know.
• 1:37
  Speaker 3: And we actually we have a Mexican hairless dog and
• 1:40
  Speaker 3: we're rubbing on our skin because she needs, like, you know,
• 1:43
  Speaker 3: some sort of barrier. And then she started growing hair,
• 1:47
  Speaker 3: so and it was like tufts of hair was almost
• 1:49
  Speaker 3: like like plugs. So we had to stop. But yeah,
• 1:52
  Speaker 3: it was growing hair, but it would be killed.
• 1:55
  Speaker 2: Would it be good to put it right on your scalp?
• 1:57
  Speaker 3: Yeah, you know, I can't say there's any study said
• 2:00
  Speaker 3: there is on the you know and the ingredies, but
• 2:02
  Speaker 3: there's no studies on that product for growing hair. But
• 2:06
  Speaker 3: we know an end of one, the dog Cleopatra. Yeah.
• 2:12
  Speaker 3: But yeah, Laurie will grab people like walking out their
• 2:15
  Speaker 3: limping or someone a wheelchair. Hey, come over here and
• 2:18
  Speaker 3: just give them peptides. Yeah, come back the next day.
• 2:21
  Speaker 3: And I swear that testimonials are amazing.
• 2:24
  Speaker 2: Well I know that, and I'm one of them.
• 2:27
  Speaker 1: So yeah, that's one of the reasons I wanted to
• 2:30
  Speaker 1: have you on is because when I try a product
• 2:33
  Speaker 1: and you know, I'll keep using yours and I'm kind
• 2:35
  Speaker 1: of running low.
• 2:36
  Speaker 2: So I'll talk to you about getting some more.
• 2:38
  Speaker 1: But when I try a product and it works, you've
• 2:42
  Speaker 1: got me sold.
• 2:43
  Speaker 2: Because there are so many dead ends. As everybody knows, you.
• 2:46
  Speaker 1: Can take lots and lots of different supplements and never
• 2:50
  Speaker 1: see results. But well, you know you're in the middle
• 2:53
  Speaker 1: of an industry. That's one of my favorite topics, and
• 2:57
  Speaker 1: that's peptide. So we'll get into the two different categories
• 3:02
  Speaker 1: of peptides.
• 3:04
  Speaker 2: But I wanted to let you know that I just I.
• 3:07
  Speaker 1: Now write an article monthly for Talk Doctor magazine in
• 3:10
  Speaker 1: addition to Ageless and Timeless.
• 3:13
  Speaker 2: And my first issue.
• 3:14
  Speaker 1: Of Talk Doctor was Jay Campbell, and he is now
• 3:19
  Speaker 1: the founder, one of the co founders of Peptide bio
• 3:24
  Speaker 1: Longevity Labs, which is they're focusing on peptide peptide.
• 3:29
  Speaker 2: Bioregulators as well as other peptides.
• 3:32
  Speaker 1: So I guess you would say they're a competitor of yours,
• 3:35
  Speaker 1: but a friendly one.
• 3:36
  Speaker 3: You know what, there's no competitors. It's it's it's like
• 3:39
  Speaker 3: being on a restaurant row. It's it's building awareness and
• 3:43
  Speaker 3: as long as they're not doing crazy crap and you
• 3:45
  Speaker 3: know everyone down there's no competitors. Well, you know the.
• 3:49
  Speaker 1: Thing is you you get your products from one of
• 3:51
  Speaker 1: my favorite people in the whole world, and that's Phil
• 3:53
  Speaker 1: Mickens and I think you still are you still working
• 3:57
  Speaker 1: together with him?
• 3:57
  Speaker 3: Oh? Yeah, we love him. Yeah, that's all horrible regulators
• 4:00
  Speaker 3: because the thing is it's very difficult to test any bioregulators,
• 4:06
  Speaker 3: So you have to really go by the you know,
• 4:10
  Speaker 3: the manufacturer and the studies that they've done on that product,
• 4:13
  Speaker 3: because anyone can say here's a bioregulator, right because it's
• 4:16
  Speaker 3: natural and you can't test it. So yeah, that that
• 4:20
  Speaker 3: is why. You know, Phil is awesome and they've been around,
• 4:23
  Speaker 3: they've they've done the right things and been connected to
• 4:26
  Speaker 3: people like yourself and RedFest and so yeah, it's about cool.
• 4:31
  Speaker 2: Well, he was one of.
• 4:32
  Speaker 1: My guests on way before people really knew what peptides are,
• 4:36
  Speaker 1: because I should say bioregulators are, and even though he
• 4:41
  Speaker 1: had other peptides that the bioregulators is where we were focused.
• 4:45
  Speaker 1: So I sent him a I think it was a
• 4:50
  Speaker 1: PayPal or whatever, like for twenty three hundred dollars. That's
• 4:53
  Speaker 1: how much faith I had in him and and now
• 4:57
  Speaker 1: he actually is one of our sponsors for the podcast,
• 5:01
  Speaker 1: so we have a very very close alignment. And also
• 5:05
  Speaker 1: he introduced me to doctor Bill Lawrence, who is the
• 5:10
  Speaker 1: protege of doctor Cavinson, who you know has passed away,
• 5:15
  Speaker 1: but doctor Cavinson is really the founder of peptide bioregulators,
• 5:21
  Speaker 1: which had been in Russia for I think sixty years
• 5:23
  Speaker 1: or so.
• 5:24
  Speaker 3: It's been amazing. The most cutting end stuff is sixty
• 5:27
  Speaker 3: years old.
• 5:27
  Speaker 2: Yeah, why is that?
• 5:30
  Speaker 3: And we find that with anything, And I tell people
• 5:32
  Speaker 3: that if you have a if you go back and
• 5:35
  Speaker 3: review the last twenty years, you take two months and
• 5:38
  Speaker 3: review all the medical literature and a specialty not like
• 5:42
  Speaker 3: surgery where you have to do something, but you would be
• 5:44
  Speaker 3: a better specialist than a specialist let's say GI or neurology.
• 5:49
  Speaker 3: I mean, there's so many great studies. All the studies
• 5:52
  Speaker 3: now are manipulated and they're basically the studies are published now,
• 5:57
  Speaker 3: fifty percent are wrong, the conclusions are bs. Yeah, that's
• 6:04
  Speaker 3: the way the world is going and something's got to change.
• 6:07
  Speaker 3: So we'll see with RFK.
• 6:08
  Speaker 1: And I was just going to say, I hope with
• 6:10
  Speaker 1: the new regime that we have a change in that
• 6:13
  Speaker 1: because so many people are fooled by these studies and
• 6:16
  Speaker 1: they don't they never asked the question like who sponsored
• 6:20
  Speaker 1: these studies? You know, if it's a cereal company and
• 6:23
  Speaker 1: they're touting processed foods and breakfast cereals.
• 6:27
  Speaker 3: You know, you look at the COVID and big agriculture,
• 6:32
  Speaker 3: it's just big pharma. It's just it's unbelievable, I know.
• 6:36
  Speaker 1: So we'll hopefully see some change there, right, Ken, Well,
• 6:39
  Speaker 1: so let's back up and tell.
• 6:41
  Speaker 2: Us about your journey.
• 6:42
  Speaker 1: You're like so many of us who had a health
• 6:45
  Speaker 1: crisis and that.
• 6:47
  Speaker 2: Really changed your life.
• 6:48
  Speaker 1: But yet you know, as they say in the Chinese say,
• 6:51
  Speaker 1: crisis and opportunity are synonymous.
• 6:54
  Speaker 2: So in your case, what exactly happened?
• 6:57
  Speaker 3: Yeah, you certainly don't see that when you're in it.
• 6:59
  Speaker 3: So you know, growing up, there was always something weird.
• 7:02
  Speaker 3: I was very functional and happy and you know, but
• 7:05
  Speaker 3: like half my body would be sweating, half would be
• 7:08
  Speaker 3: freezing cold. My arm would stop working, my hands were
• 7:12
  Speaker 3: so cold, I couldn't shake hand. Okay, you know, no
• 7:15
  Speaker 3: one could could figure it out. But in no worries,
• 7:17
  Speaker 3: it worked. And then went through college and got to
• 7:20
  Speaker 3: medical school, it started getting something's going on. It just
• 7:24
  Speaker 3: like so everything was so overwhelming, Like talking to a
• 7:28
  Speaker 3: patient was just oh my gosh, it was just overwhelming.
• 7:31
  Speaker 3: So anxiety, uh, and people that have a kind of
• 7:35
  Speaker 3: you know, it's kind of a brain fog, but just
• 7:37
  Speaker 3: you can't hold toward any stress, especially emotional stress or
• 7:40
  Speaker 3: you know, psychological stress. And so I'm like, I can't
• 7:43
  Speaker 3: do this. I'll have to drop out. And but I
• 7:46
  Speaker 3: was very evidence based. I'm still very evidence based. But
• 7:49
  Speaker 3: it is ingrained in you that anything alternative, integrative, functional
• 7:54
  Speaker 3: is bogus. It means no evidence. I believe that. But
• 7:58
  Speaker 3: you know, I went to all these top notch university
• 8:01
  Speaker 3: specialists like, well, you're is depressed. I'm like, I'm not depressed.
• 8:04
  Speaker 3: I took your enterpresident, da da, I didn't do anything
• 8:07
  Speaker 3: because I'm telling you that's not it. And so finally
• 8:09
  Speaker 3: I snuck off. I went to anesthesia because you don't
• 8:11
  Speaker 3: have to talk to patients, and I'm like that's the
• 8:13
  Speaker 3: only thing I could do. But I was I was
• 8:15
  Speaker 3: circling the drain there and went to these integrative you know,
• 8:18
  Speaker 3: alternative conferences. I'm like, this is more evidence based than
• 8:23
  Speaker 3: the crap they're feeding us, you know, and it's like,
• 8:26
  Speaker 3: oh my god. So I left started doing those things
• 8:29
  Speaker 3: and I just dramatic improve and I wasn't one hundred percent,
• 8:33
  Speaker 3: but you know, with vibrate aptimization, which is oh my god,
• 8:37
  Speaker 3: that is number one. If you just do that with people,
• 8:40
  Speaker 3: eighty percent, people will get better. And some anti virals
• 8:43
  Speaker 3: might achondro boosting, you know, and immune modulation, and I'm like,
• 8:47
  Speaker 3: I'm great. But then I basically going through after residency
• 8:51
  Speaker 3: and got out and then went through a stress for divorce.
• 8:54
  Speaker 3: Emotional stress is so impactful. It is stressed out well
• 9:00
  Speaker 3: do the boor you know, But what it does. You know,
• 9:03
  Speaker 3: people think emotional stress lowers immunity. It doesn't. It modulates it,
• 9:07
  Speaker 3: so it lowers the THH one so you can't fight
• 9:10
  Speaker 3: intertellar infections or cancer. But instead of lowering everything, it
• 9:13
  Speaker 3: raises that THH too, so you get all this inflammation
• 9:17
  Speaker 3: and aging. And that's where people are, oh my gosh,
• 9:20
  Speaker 3: you look terrible. So with that and then I just crashed.
• 9:24
  Speaker 3: I was bedbound sweating and actually was you know, I
• 9:28
  Speaker 3: was diagnosed, you know, with carnefidigue syndrome, which is a
• 9:31
  Speaker 3: ridiculous diagnosis because they don't. It allows doctors to not
• 9:36
  Speaker 3: understand or try to find the underlying condition. But I
• 9:38
  Speaker 3: had lime babisia bartonella, and I could not get out
• 9:43
  Speaker 3: of bed. And I was going to off myself and said,
• 9:46
  Speaker 3: I I'm going to give up. I'll give a year,
• 9:49
  Speaker 3: I'll go in around the world. I could not. I
• 9:51
  Speaker 3: went into heart failure. My heart was fibrosed because of
• 9:55
  Speaker 3: high human truswork with vector beta, which is a key
• 9:58
  Speaker 3: marker for so many people, anyone with sears, you know,
• 10:01
  Speaker 3: mold toxicity, chronic fatigue, syndrome, fire, malgia. You want to
• 10:06
  Speaker 3: check your human transfer and growth factor beta at QUEST,
• 10:08
  Speaker 3: not lab Gore even they're terrible, but and Quest is
• 10:13
  Speaker 3: the worst customers forever. But but there and uh and
• 10:16
  Speaker 3: it causes fibrosis. So my heart was fibros and they
• 10:19
  Speaker 3: and the cardiologist said maybe in ten years you get
• 10:21
  Speaker 3: timbercent better. I could not stand up, I could not
• 10:24
  Speaker 3: walk upstairs. And so I went around the country and
• 10:28
  Speaker 3: the world bent over looking for treatments. And I was
• 10:31
  Speaker 3: in Belgium and I did peptides. I didn't think any
• 10:33
  Speaker 3: of the peptides. And then two days later I just
• 10:37
  Speaker 3: walked up the flight of stairs, I'm like, wait a minute,
• 10:39
  Speaker 3: and then backtracked and oh, my gosh, it's the peptides.
• 10:43
  Speaker 3: And then so it took two years to bring them
• 10:44
  Speaker 3: out to the United States and that kind of, you know,
• 10:48
  Speaker 3: set things off, and this book for Taylor made so
• 10:50
  Speaker 3: they were big and bringing those in but my life
• 10:55
  Speaker 3: and it's changed patient's life. Every doctor we train on
• 10:59
  Speaker 3: them is change their.
• 11:01
  Speaker 4: Today's podcast is brought to you by International Anti Aging
• 11:04
  Speaker 4: Systems and Profound Health. The founder, Phil Mickens has been
• 11:09
  Speaker 4: a guest on Ageless and Timeless, and those who know
• 11:13
  Speaker 4: him personally, as I am so fortunate to do, can
• 11:16
  Speaker 4: attest to his knowledge, experience, authenticity, and his passion to
• 11:21
  Speaker 4: help make the world a better place with a commitment
• 11:24
  Speaker 4: to work profoundly to improve our health. I personally have
• 11:29
  Speaker 4: used the peptide bioregulators, some of his hormones and his
• 11:33
  Speaker 4: skincare products, and I can attest to their efficacy. If
• 11:37
  Speaker 4: you want those unique and value added, evidence based health products,
• 11:41
  Speaker 4: then IAS and Profound Health are your number one resource.
• 11:45
  Speaker 4: We're going to flash on the.
• 11:46
  Speaker 1: Screen the different websites that you can use in order
• 11:49
  Speaker 1: to order their products and no matter which website you
• 11:53
  Speaker 1: go to and which products you order, please use the
• 11:56
  Speaker 1: Ageless code for a fifteen percent discount.
• 12:00
  Speaker 2: Yeah, because you and.
• 12:01
  Speaker 1: I also share another person that we love in common,
• 12:03
  Speaker 1: and that's Ryan Smith, and he was at Taylor Made
• 12:06
  Speaker 1: right where he's when you were a Yeah, So have.
• 12:11
  Speaker 2: You done all his true diagnostic testing now?
• 12:14
  Speaker 3: Yeah? Yeah, So we totally use that and we're going
• 12:17
  Speaker 3: to be launching a longevity program where we're going to
• 12:20
  Speaker 3: guarantee five year reduction and biologic age over two years.
• 12:25
  Speaker 2: Oh when you say, well, you mean Integrated PET guys.
• 12:28
  Speaker 3: Uh, no, a whole dire of medical group.
• 12:30
  Speaker 2: Oh you're that's your other company.
• 12:32
  Speaker 3: Yeah, so because it's a clinical thing, so yeah, integrat PET.
• 12:36
  Speaker 3: We don't treat patients something the company, so that that's
• 12:39
  Speaker 3: our treatment side.
• 12:40
  Speaker 2: Right.
• 12:41
  Speaker 1: So you know with doctor Morrence, you have to take
• 12:44
  Speaker 1: the true diagnostics test and the Telemere test as the
• 12:48
  Speaker 1: baseline before you can started his clinical trials for the bioregulators.
• 12:54
  Speaker 1: So he puts a lot of faith into Ryan and
• 12:57
  Speaker 1: the company, And of course now they've expanded so that
• 13:00
  Speaker 1: you're not only getting your true age biological aid versus cronologue,
• 13:05
  Speaker 1: but you're also getting your organ age.
• 13:08
  Speaker 3: So yeah, I know, I love how they expand I
• 13:11
  Speaker 3: mean they're kind of algorithmic and biomarkers, but they all
• 13:14
  Speaker 3: really hold up to scrutiny when you look at the
• 13:17
  Speaker 3: medical literature and you know the big things methilation that telomeres.
• 13:21
  Speaker 3: Telomere has changed much quicker than the methilation. And then
• 13:25
  Speaker 3: but you add in, you know, the bio markers and
• 13:27
  Speaker 3: they're all valid. It's not like this one's good, this
• 13:29
  Speaker 3: one's bad. Uh. They all are different, but you know,
• 13:33
  Speaker 3: it's kind of a blend, so they all play a part.
• 13:36
  Speaker 3: And Ryan's just very brilliant and and just bringing new
• 13:41
  Speaker 3: stuff out and whatever company works for, it's amazing. So yeah,
• 13:45
  Speaker 3: we're big fans.
• 13:46
  Speaker 2: He makes it look so easy.
• 13:48
  Speaker 1: I told him when I saw him at the show recently,
• 13:51
  Speaker 1: I said, Ryan, you've accomplished so much in just a year.
• 13:55
  Speaker 1: And he's actually coming back on my podcast next month
• 14:00
  Speaker 1: of July third because there's so much has happened since
• 14:05
  Speaker 1: when he first appeared. So he's like a whirling dervish.
• 14:11
  Speaker 3: And you know what I mean, it is a great
• 14:12
  Speaker 3: time to be alive. It's pretty crazy. But in terms
• 14:16
  Speaker 3: of you know, longevity and medicine read. Things are happening,
• 14:20
  Speaker 3: but they're not in standard medicine. Standard medicine moves so slow.
• 14:25
  Speaker 3: So Anaal's of Internal Medicine Show basically published a review
• 14:29
  Speaker 3: article showing that most doctors practice ten to twenty years
• 14:33
  Speaker 3: behind what's available the medical literature, and it takes on
• 14:37
  Speaker 3: average a proven, proven new therapy to get accepted into
• 14:43
  Speaker 3: mainstream medicine seventeen years on average. And why is that, Well, one,
• 14:50
  Speaker 3: doctors don't read medical journals. Okay, that's that's true. They
• 14:54
  Speaker 3: say they do, but they don't. They if they even
• 14:56
  Speaker 3: read the abstracts, they won't read them. But even more
• 14:59
  Speaker 3: important is if you give them here's ten studies, twenty studies,
• 15:03
  Speaker 3: fifty studies showing that here's a better way, a new
• 15:07
  Speaker 3: you know therapy or you know, diagnostic criteria. They go, no, no, no,
• 15:13
  Speaker 3: my patients are different. I'm fine, My patients aren't like that.
• 15:17
  Speaker 3: They just they're not evident space. The most doctors are
• 15:21
  Speaker 3: doing what they learned ten years, twenty years ago. And
• 15:25
  Speaker 3: those of these are the experts. Yeah, and it's crazy
• 15:29
  Speaker 3: and they just pooh pooh, and you know, they were adamant.
• 15:31
  Speaker 3: They're right, and the more adamant of the doctor's right,
• 15:33
  Speaker 3: the less they know. So you know, the really the
• 15:38
  Speaker 3: where the action's happening is this integratable alternative space.
• 15:42
  Speaker 2: Yeah.
• 15:42
  Speaker 1: I often say when I talk to people like you
• 15:46
  Speaker 1: that that one talk that Peter Diamandis gave it a
• 15:50
  Speaker 1: four M two years ago. He was the keynote and
• 15:53
  Speaker 1: he said, in the last ten years we've accomplished more
• 15:58
  Speaker 1: in functional medicine and in the last one hundred years
• 16:02
  Speaker 1: of medicine allopathically.
• 16:04
  Speaker 2: So that right there says so much. And with you know,
• 16:08
  Speaker 2: all the technology available now.
• 16:10
  Speaker 1: And AI and and like you said, DNA methylation and
• 16:15
  Speaker 1: you know all these ways to test.
• 16:18
  Speaker 3: But I'm telling you, it's like there's so many things
• 16:21
  Speaker 3: against like forward thinking doctors. Yes, if you are treating
• 16:27
  Speaker 3: cancer and curing it, you'll lose your license.
• 16:30
  Speaker 2: Yeah, well or escape to Mexico or some.
• 16:34
  Speaker 3: No, it's scary. So we have some mecanomic private Medical
• 16:38
  Speaker 3: Association and IRBs, but it's like you have to have
• 16:43
  Speaker 3: basically a war chest of money to fight them off
• 16:47
  Speaker 3: because they will come after you. And it is not
• 16:50
  Speaker 3: because you're providing poor care. It's because you're curing people.
• 16:54
  Speaker 2: Because you are curing people. I know.
• 16:56
  Speaker 1: It's well, let's again, let's hope that this is paradigm shift.
• 17:00
  Speaker 1: It's going to occur with the change of the leadership.
• 17:05
  Speaker 1: So okay, So back to where we were. So you've
• 17:09
  Speaker 1: discovered peptides by accident because you were in Belgium, you
• 17:13
  Speaker 1: were desperate for a cure. You didn't know what you had,
• 17:17
  Speaker 1: so you're kind of like you had blind poles on,
• 17:19
  Speaker 1: just you know, stabbing looking for answers that people were
• 17:23
  Speaker 1: giving you all over the map, and most of them
• 17:26
  Speaker 1: were wrong.
• 17:26
  Speaker 2: But then these.
• 17:27
  Speaker 1: Peptides, what what peptides did you actually take in those
• 17:31
  Speaker 1: first two you know what to change you?
• 17:34
  Speaker 3: And I don't totally remember, because when you don't know
• 17:37
  Speaker 3: what they are, I just have peptide. You just take them,
• 17:40
  Speaker 3: Like what the hell was that I do? But I'm
• 17:42
  Speaker 3: sure it was like diamus and alpha one yeah for
• 17:46
  Speaker 3: you know, yeah, the but it's like but there you
• 17:49
  Speaker 3: bring them in, it's like and there's so many and
• 17:52
  Speaker 3: all these studies are again forty fifty years old, and
• 17:55
  Speaker 3: you getting a buyer regulators, which we'll talk about. I'm sure, yeah, crazy, I.
• 17:59
  Speaker 1: Say, people don't most people don't realize that insulin is
• 18:04
  Speaker 1: a peptide, and it was you know, that was around
• 18:06
  Speaker 1: in the early nineteen hundreds, right, So.
• 18:08
  Speaker 3: Well it's a protein because they changed the definition of peptide.
• 18:12
  Speaker 3: That's true.
• 18:13
  Speaker 2: That's true. Well let's go into that definition.
• 18:17
  Speaker 3: But you know what's interesting, like nasal insulin hashwn to
• 18:23
  Speaker 3: totally benefit dementia and lower butcher, but they can't detect
• 18:28
  Speaker 3: it in the blood. It has some you know, basically
• 18:32
  Speaker 3: activity not getting in the blood. So I mean, it's
• 18:35
  Speaker 3: just amazing stuff. Anyways, that's kind of a side don't
• 18:37
  Speaker 3: well here.
• 18:38
  Speaker 1: Last night I was watching j Campbell on a podcast
• 18:40
  Speaker 1: and I can't remember the name of the.
• 18:44
  Speaker 2: Host, but they seem to know each other from athletics.
• 18:47
  Speaker 3: Because this, uh was a Turkish bathhouse. They know each other, oh.
• 18:56
  Speaker 2: Well, wherever it was.
• 18:58
  Speaker 1: They went through every single pep tide to talk about
• 19:03
  Speaker 1: what they do and what their benefits are and so on.
• 19:06
  Speaker 1: And I thought, you know, and it was because I
• 19:09
  Speaker 1: was going to have you on here today and I
• 19:11
  Speaker 1: thought if.
• 19:11
  Speaker 2: We ever did that, we'd be here all for twenty.
• 19:14
  Speaker 3: Four Oh my god. It is it just Also every
• 19:18
  Speaker 3: month there's more and more and you go back and
• 19:21
  Speaker 3: then the farther you go back, and they're they're great studies,
• 19:24
  Speaker 3: even better studies that are older studies. People are like, oh,
• 19:26
  Speaker 3: I didn't want this latest year. Yeah, it's just you know, bogus.
• 19:29
  Speaker 3: But yeah, it's just incredible the amount of literature that
• 19:33
  Speaker 3: is out there that is actually it's it's basically suppressed
• 19:37
  Speaker 3: or ignored. I would say, well.
• 19:39
  Speaker 1: I mean, we know there's twenty one bioregulators, but how
• 19:42
  Speaker 1: many heptides are there?
• 19:44
  Speaker 3: There's actually thirty four bioregulators.
• 19:48
  Speaker 2: Oh they've they've gone up.
• 19:50
  Speaker 3: Okay, well, well we have fourteen of them that no
• 19:54
  Speaker 3: one else has, but we have like mitochondri bioregular stem
• 19:58
  Speaker 3: cell bioregulars and yeah, the next month.
• 20:02
  Speaker 2: I want I want to hear about that.
• 20:04
  Speaker 1: I know that that's something that's brand new, but so
• 20:07
  Speaker 1: so how many other peptize, the original synthetic injectable peptize,
• 20:13
  Speaker 1: how many are there that are available?
• 20:15
  Speaker 3: I mean there's thousands of those. Oh, and the thing
• 20:20
  Speaker 3: is it's just how commercially viable are there. They're like,
• 20:24
  Speaker 3: you know, look at cloth. Oh, oh my gosh, it's amazing.
• 20:27
  Speaker 3: It's just but it's a very complex molecule. It costs.
• 20:31
  Speaker 3: It's so expensive to inject, and I mean it's sort
• 20:35
  Speaker 3: of anti aging, anti inflammatory, but it's going to cost you,
• 20:40
  Speaker 3: you know, three thousand dollars a month to do, you know.
• 20:44
  Speaker 3: So it's that spectrum. So there's so many I mean,
• 20:48
  Speaker 3: they can synthesize any basically peptid your body now, but
• 20:52
  Speaker 3: just doesn't make sense.
• 20:53
  Speaker 1: Yeah, well, so I know that you have been very
• 20:58
  Speaker 1: gracious about giving us a little graphic presentation, and Tony
• 21:03
  Speaker 1: has your link, so he's going to show that. Just
• 21:06
  Speaker 1: tell me what before we get into the graphics, Let's
• 21:11
  Speaker 1: tell everybody the distinction between peptide and peptide.
• 21:14
  Speaker 3: Bioregulators awesome, And so people say, what is a peptide? Yeah,
• 21:20
  Speaker 3: people think of like you know, collagen peptides, and they
• 21:23
  Speaker 3: are peptides. So peptides amino acid and people are used
• 21:27
  Speaker 3: to proteins, which by arbitrary definition, if they're greater than
• 21:32
  Speaker 3: it was sixty then fifty to forty forty amino acids.
• 21:35
  Speaker 3: It's a protein like insulin, which now is a protein,
• 21:39
  Speaker 3: but it's less than that. It's a peptide. And most
• 21:42
  Speaker 3: of the peptides work basically they go on the cell surface,
• 21:46
  Speaker 3: attached to receptor. Then they have secondary effects and secondary
• 21:49
  Speaker 3: signaling molecules, very pleotrophic, very much like kind of supplements
• 21:54
  Speaker 3: where multiple effects. So they may increase in enzyme block
• 21:59
  Speaker 3: and zome TME or you know, a change metabolic activity
• 22:05
  Speaker 3: of the cell. Now, bioregulators are are a subset of peptides.
• 22:10
  Speaker 3: There are only two to four amino acids in lengths,
• 22:14
  Speaker 3: so very small and what they work very differently, so
• 22:18
  Speaker 3: they'll go into the Basically they're very orally bioavailable as
• 22:24
  Speaker 3: long as there if you take them as a salt,
• 22:27
  Speaker 3: let's say an arginine salt, like BPC salt, it's called
• 22:32
  Speaker 3: stable BPC, should be unstable bpc. But and let's say
• 22:37
  Speaker 3: it's capped and the body will setylate and amitate. They'll
• 22:41
  Speaker 3: cap any peptide that is important so it doesn't get
• 22:45
  Speaker 3: broken down. So these peptides we make, we cap them
• 22:48
  Speaker 3: and then so they get into the system very high bioavailability.
• 22:52
  Speaker 3: Then they go into the blood to the cells, into
• 22:56
  Speaker 3: the inside the cell that into the nucleus and bind
• 22:59
  Speaker 3: to repressors and UH and activators of genes, so they
• 23:04
  Speaker 3: work epigenetically. They turn genes on and turn genes off,
• 23:08
  Speaker 3: so they work very different than attaching to the cell
• 23:12
  Speaker 3: surface and activating a pleiotrophic effect.
• 23:16
  Speaker 2: Yeah, So there tissues tissue specific or organ specific, whereas
• 23:20
  Speaker 2: the other peptides, the original ones are they just go anywhere, right,
• 23:26
  Speaker 2: I mean there.
• 23:27
  Speaker 3: And yeah, and they tend to be very much more
• 23:30
  Speaker 3: specific than hormones or peptides or supplements or medications there.
• 23:37
  Speaker 3: If you take it from the thymus, it will work
• 23:39
  Speaker 3: on the thymus gland. There's certainly some crossover, which is good,
• 23:44
  Speaker 3: but they'll tend to focus on that epigenetic. They'll turn
• 23:49
  Speaker 3: the which thankfully the basically anti aging genes, and they'll
• 23:56
  Speaker 3: turn off the sick genes the sick phenotype, and they
• 24:01
  Speaker 3: basically also it's good. As you get older, you stop
• 24:04
  Speaker 3: producing basically the cells stop, they get lazy. Yeah, you
• 24:08
  Speaker 3: stop producing protein. So it's one of the hallmarks of
• 24:12
  Speaker 3: aging that you just you don't make as much. And
• 24:15
  Speaker 3: so we'll turn that back on, like mitochondrial function and
• 24:20
  Speaker 3: basically so turn those on any tissue specific way. So
• 24:24
  Speaker 3: if you need the liver to function better, and so
• 24:27
  Speaker 3: it starts functioning better as it was when it was
• 24:30
  Speaker 3: twenty years old or at the heart and reverse heart disease,
• 24:33
  Speaker 3: and it's just amazing or fertility, Oh my gosh, we're
• 24:37
  Speaker 3: doing just amazing fertility stuff. It's anti aging the ovaries
• 24:41
  Speaker 3: and the whole system. And when you come now, when
• 24:44
  Speaker 3: you stack those bioregulators, that's where you get the real power.
• 24:48
  Speaker 1: So what for example, take BPC one fifty seven, which
• 24:51
  Speaker 1: is probably the most popular or well known of the
• 24:55
  Speaker 1: traditional pep does not to bioregulators. But if you took
• 24:59
  Speaker 1: that and you were going to acket to go after
• 25:03
  Speaker 1: joint or tissue injuries, what would you stack it with?
• 25:08
  Speaker 3: Yeah, And so there's so many different ways. And with
• 25:13
  Speaker 3: BPC is so great, and people think as a gut
• 25:16
  Speaker 3: peptide because that's where it is produced. And for instance,
• 25:19
  Speaker 3: if you add BPC and KPV, which is a tripeptide
• 25:26
  Speaker 3: of melanocyte stimulating hormone, and it happens to be hugely
• 25:30
  Speaker 3: anti inflammatory, but it doesn't suppress the immunity, right, everything
• 25:35
  Speaker 3: anti inflammatory expressed immunity, and it's anti microbial. So it's
• 25:39
  Speaker 3: more potent than basically diflucan against mold and basically typical
• 25:47
  Speaker 3: antibiotics against like toxic staff aureas and it's it's lowering
• 25:52
  Speaker 3: inflammation and boosting your immune system. So it also works
• 25:58
  Speaker 3: on the gut lining, so BBC will rejuvenate everyone has
• 26:02
  Speaker 3: leaky gut. All this stuff because all the toxins, and
• 26:05
  Speaker 3: then you add for instance, TB four so thiamusin beta four.
• 26:09
  Speaker 3: It goes to wherever there is damage. And you look
• 26:13
  Speaker 3: at let's say COVID patients that are in the ICU,
• 26:18
  Speaker 3: they don't have any t before the body. The virus
• 26:21
  Speaker 3: suppressed it. And a big reason they're finding is that
• 26:24
  Speaker 3: the lung cells can't secrete T before to rejuvenate, and
• 26:29
  Speaker 3: they found that the giving that, but it rejuvenates all
• 26:32
  Speaker 3: the tissues. But the big problem is because normally, if
• 26:36
  Speaker 3: you need to heal something, you know basically all the
• 26:40
  Speaker 3: mass cells need to be activated to go heal. But
• 26:44
  Speaker 3: we have so many people with chronic illness that have
• 26:46
  Speaker 3: mass sele activation syndrome, chronic canflanneatory response syndrome, Chrodt syndrome.
• 26:51
  Speaker 3: Their mass cells are already totally activated. So if you
• 26:53
  Speaker 3: eat t BE four, you're activating all the mass cells
• 26:56
  Speaker 3: because it is a multi domain one hundred and forty
• 26:59
  Speaker 3: three amino acids. But TV four FRAG does basically the
• 27:03
  Speaker 3: immune modulation of TV four and the healing, but leaves
• 27:07
  Speaker 3: out the bad parts for most of partic illness. And
• 27:11
  Speaker 3: you can staff all those things like BPC, TV four
• 27:14
  Speaker 3: FRAG and TB four FRAG specifically will target the tight
• 27:18
  Speaker 3: junction and heal those in the gut, and then you
• 27:22
  Speaker 3: get KPV with it. So many people with chrones that
• 27:24
  Speaker 3: they are coming in like a twelve year old kid
• 27:27
  Speaker 3: with they want to take out their colon and they
• 27:30
  Speaker 3: so quick to do that. We're like, no, no, no, no,
• 27:32
  Speaker 3: because they failed all the other treatments and within you know,
• 27:36
  Speaker 3: a month of six weeks they're totally fine.
• 27:39
  Speaker 1: So BPC one, if it's for the gut, isn't it
• 27:44
  Speaker 1: better to do it orally? But if it's flored the joints,
• 27:47
  Speaker 1: it's better to inject it and to try to inject
• 27:50
  Speaker 1: it right into the site where the trauma is.
• 27:54
  Speaker 3: Yeah. So people say, you know, oh, oropeptides and they
• 27:58
  Speaker 3: don't absorb their right for the larger peptides and even
• 28:03
  Speaker 3: maybe smaller pep if they're not capped. But studies have shown,
• 28:07
  Speaker 3: for instance, BBC, if it's capped, seolated and emmidated and
• 28:11
  Speaker 3: that's what they do gre peptides. That it is equal potent.
• 28:14
  Speaker 3: Every study is shown equal potent to basically sub q
• 28:18
  Speaker 3: I M even you know I V it's it's equal potent.
• 28:22
  Speaker 3: It gets the exact same effects. Now, if you have
• 28:26
  Speaker 3: a joint problem, you ejected in the joint, Yes, that
• 28:29
  Speaker 3: that's going to have more effect inside the joint.
• 28:32
  Speaker 1: Right, Okay, So in your personal case, which would you
• 28:37
  Speaker 1: if you had to make a choice, would you take
• 28:40
  Speaker 1: a course of bioregulators before peptides are the or would
• 28:44
  Speaker 1: you combine them? Or how would you you know, make
• 28:47
  Speaker 1: your selection for something that's a vast array of possibilities.
• 28:53
  Speaker 3: Yeah, I mean, I think the thing is is the
• 28:56
  Speaker 3: stacking and combinations is so powerful and all even we
• 29:00
  Speaker 3: see for all my sins, I guess all this the
• 29:02
  Speaker 3: sick of the sick, right, that have been everywhere in
• 29:05
  Speaker 3: multi system illness, and we should try to see healthy paces.
• 29:09
  Speaker 3: I've seen one but that I'll often prescribe ten twelve
• 29:16
  Speaker 3: peptides and bioregulators together on the initial visit, you know,
• 29:20
  Speaker 3: based on their symptoms, and then the labs always supported
• 29:24
  Speaker 3: and never an issue with that because there's no the
• 29:27
  Speaker 3: side effects are so low right, and because they all
• 29:33
  Speaker 3: really are so synergistic that you know, And the problem is,
• 29:37
  Speaker 3: I can give you a thousand supplements that are good
• 29:40
  Speaker 3: for you, but which ones are going to make a difference.
• 29:42
  Speaker 3: The difference is that they do make a difference. And
• 29:46
  Speaker 3: people say, well, how do I know what's gonna was working?
• 29:48
  Speaker 3: If you know? If I take all those, well, when
• 29:52
  Speaker 3: you feel so much better, then we'll figure it out.
• 29:54
  Speaker 3: Then we'll drop them, right, So we just drop one
• 29:56
  Speaker 3: at a time. But usually because what you find is
• 29:59
  Speaker 3: if you you let's say bioregular a or and then
• 30:04
  Speaker 3: peptide B or bier or C. You do one at a time. Oh,
• 30:08
  Speaker 3: I didn't really notice anything. You do them together. Oh
• 30:10
  Speaker 3: my gosh, I feel so much better.
• 30:13
  Speaker 2: So do you actually formulate them?
• 30:16
  Speaker 1: When patients come in, then you just interview them, look
• 30:20
  Speaker 1: at their labs, and then you come up with a
• 30:22
  Speaker 1: class customize peptide program that that is, you know, obviously
• 30:29
  Speaker 1: collecting the stacking the peptides, like you said, is that
• 30:33
  Speaker 1: how you Oh?
• 30:34
  Speaker 3: Yeah, My problem is I love seeing patients and I'm
• 30:37
  Speaker 3: not very financially down with it. And I'll spend four
• 30:41
  Speaker 3: hours with patients and yeah, yeah, and I can't understand
• 30:46
  Speaker 3: how doctors are spending you know, ten minutes, twenty minutes,
• 30:49
  Speaker 3: like I can't see high in that time.
• 30:51
  Speaker 2: I know. It's that's part.
• 30:54
  Speaker 1: Of why our healthcare system is so broken, is the
• 30:56
  Speaker 1: insurance companies are mandating these abbreviated interview times.
• 31:02
  Speaker 2: How could you possibly get to know what.
• 31:03
  Speaker 1: Patient's needs in a fifteen minute discussion?
• 31:08
  Speaker 2: It's ridiculous.
• 31:09
  Speaker 1: So all right, well let's talk about and then I
• 31:12
  Speaker 1: want to make sure we have time to the sideshow.
• 31:14
  Speaker 1: So in the side show, this was your talk at
• 31:17
  Speaker 1: a four M? Is that what we're going to see?
• 31:19
  Speaker 3: And yeah, we kind of combined the uh just a
• 31:22
  Speaker 3: few slides from a four M and uh look Bradfast Yeah.
• 31:28
  Speaker 1: Okay, So would this be a good time to do
• 31:30
  Speaker 1: that or would you rather go for just one of
• 31:33
  Speaker 1: the conditions that people are going to be treating.
• 31:35
  Speaker 3: Yeah, that sounds good.
• 31:37
  Speaker 1: We'd rather see the sideshow now, okay, yeah, all right,
• 31:41
  Speaker 1: are you gonna you want to do it or do
• 31:42
  Speaker 1: you want Tony, our.
• 31:45
  Speaker 2: Production person, to do it?
• 31:47
  Speaker 3: Well, I don't know if we can put it up
• 31:49
  Speaker 3: from here. I don't know.
• 31:50
  Speaker 2: Okay, usually on zoom, but Tony, are you there?
• 31:54
  Speaker 1: I am, okay, can you go ahead and put the
• 31:58
  Speaker 1: sideshow up? So can can there we go? So, Ken,
• 32:01
  Speaker 1: do you want to talk about what these are?
• 32:04
  Speaker 3: Yeah? So this is basically the fire the thymous activity
• 32:10
  Speaker 3: with age.
• 32:11
  Speaker 2: It's so small for me, Tony, we lost this slide.
• 32:16
  Speaker 3: No, it's okay, I have it. So what the shows
• 32:20
  Speaker 3: is through the ages that the thymous Tony involutes. So
• 32:24
  Speaker 3: it's right here in the breast bone.
• 32:26
  Speaker 2: Yeah.
• 32:26
  Speaker 3: Famous controls the immune system. Yeah, okay, the T one
• 32:34
  Speaker 3: T two and again any model of the immune system
• 32:38
  Speaker 3: is an oversimplification, but this works for clinical THCH one
• 32:42
  Speaker 3: gets stuff inside the cell TA, you get stuff outside
• 32:44
  Speaker 3: the cell. You can have t rags over here and
• 32:47
  Speaker 3: TEACH seventeen, which causes autoimmunity. So as you get older
• 32:51
  Speaker 3: or sick or stressed or toxins or whatever exposed to that,
• 32:56
  Speaker 3: TCH one goes down and the THH two TACH seventeen
• 32:59
  Speaker 3: goes up. So now you can't fight infections, you can't
• 33:03
  Speaker 3: fight cancers, but now you have all this inflammation, all
• 33:08
  Speaker 3: this autoimmunity, uh, and all these symptoms neuro degenerate disease.
• 33:13
  Speaker 3: And it's like this, and as you get older, that
• 33:16
  Speaker 3: you can tell how old someone is by their immune
• 33:19
  Speaker 3: system and what likely their multi system illnesses are. So
• 33:24
  Speaker 3: but if you and people so that all these studies
• 33:27
  Speaker 3: showing that, well we're going to rejuvenate the thymus, you know,
• 33:30
  Speaker 3: giving growth hormone and met foreman and you know, but
• 33:34
  Speaker 3: why not just give fybming peptides. We've been doing it.
• 33:37
  Speaker 3: It's so safe, you can't overdose, and you just modulate it.
• 33:41
  Speaker 3: So you raise that teach one, lower that teach too,
• 33:43
  Speaker 3: and the lower the teach to is bpc fifty seven kpv.
• 33:48
  Speaker 3: And now you raise that teach one with like diiamen
• 33:50
  Speaker 3: G and alpha one which is ylin, which bioregulators uh
• 33:54
  Speaker 3: and the thymus, and now you modulate those and all
• 33:58
  Speaker 3: of a sudden, all all that vicious cycle of aging
• 34:03
  Speaker 3: and chronic disease where you get hypoethlamic pineal pituitary you know,
• 34:10
  Speaker 3: basically hormone levels are low, you get mitochondrial dysfunction, you
• 34:16
  Speaker 3: can't DETOXI five, you get little hormones, and it's just
• 34:20
  Speaker 3: a vicious cycle. But now it unravels, so you go
• 34:24
  Speaker 3: the other way, and now you become a younger phenotype
• 34:28
  Speaker 3: instead of being that age phenotype. So the things that
• 34:31
  Speaker 3: work for that are the thymic peptide. So instead of
• 34:36
  Speaker 3: trying to rejuvenate the thymis, just give the thymic peptides.
• 34:39
  Speaker 3: It's kind of like hormone replacement, right, and they're cheap
• 34:42
  Speaker 3: and safety, you can't overdose. And and with that, and
• 34:46
  Speaker 3: now we'll probably talk about bioregulators at this point because
• 34:51
  Speaker 3: when cavisin uh and and uh you know here, so
• 34:57
  Speaker 3: let's kind of take a step back and and so
• 35:00
  Speaker 3: how did these kind of come about? So the during
• 35:04
  Speaker 3: the Soviet Union they found that they're fighter pilots, their cosmonauts,
• 35:10
  Speaker 3: their sub mariners all were aging dramatically fast, like what's
• 35:16
  Speaker 3: going on. So they went to the KGB hospital and
• 35:19
  Speaker 3: they talked to Cavison and Pavlov as in Pavlov's dog,
• 35:25
  Speaker 3: the same same guy, and they're like, you need to
• 35:28
  Speaker 3: fix this or you know, we'll see what happens. They're like, okay,
• 35:31
  Speaker 3: we we'll fix this. They must have been doing because
• 35:34
  Speaker 3: Pavlov was doing the studies on basically extracts, and they
• 35:39
  Speaker 3: found that the extract from the thymus in the neo
• 35:43
  Speaker 3: gland right in the middle of the brain, which is
• 35:47
  Speaker 3: that I basically Toty reversed their rapid aging and they're like, okay, awesome,
• 35:55
  Speaker 3: and but no one knew and so it was a
• 35:57
  Speaker 3: it was a Soviet military secret, only given to the
• 36:00
  Speaker 3: military and the Olympic team. Olympic team did pretty well
• 36:04
  Speaker 3: right during that time, and then with the fall of
• 36:06
  Speaker 3: the Soviet Union, they all of a sudden they started publishing.
• 36:10
  Speaker 3: But it's in Russian. It's gonna he's gonna read it, right,
• 36:13
  Speaker 3: and so like forty years later, like damn, look at this,
• 36:16
  Speaker 3: you know, the translator like, there some interesting studies. So
• 36:21
  Speaker 3: it started getting more noticed and uh, and they started
• 36:24
  Speaker 3: publishing in English and that's where it basically started taking off.
• 36:29
  Speaker 3: And like we have we've hired a Russian researcher, so
• 36:32
  Speaker 3: we can go dig into that stuff. But it's really
• 36:36
  Speaker 3: interesting how it was a Soviet secret for a long time.
• 36:41
  Speaker 2: Yeah, well they could in the Soviet Union, they could
• 36:44
  Speaker 2: buy them in drug stores.
• 36:46
  Speaker 1: I mean, they were readily available, but they would not
• 36:48
  Speaker 1: let them go be exported. I guess I think maybe
• 36:53
  Speaker 1: with the Ukraine War it's only become more difficult for
• 36:57
  Speaker 1: the supply chain. But they have now made an aggressive.
• 37:01
  Speaker 1: You know, this is again tribute to Bill Lawrence who
• 37:04
  Speaker 1: went and knocked on their door and said, hey, you know,
• 37:09
  Speaker 1: he had his own health crisis. Is not as bad
• 37:14
  Speaker 1: as yours. It was more like a genetic thing where
• 37:18
  Speaker 1: the age of his relatives were all They all mortality
• 37:23
  Speaker 1: rate was in their early seventies and he was already
• 37:26
  Speaker 1: seventy three.
• 37:28
  Speaker 2: So he said, I don't want to die. I want
• 37:30
  Speaker 2: to find answer.
• 37:31
  Speaker 1: He gave up his real estate career and got his PhD.
• 37:35
  Speaker 1: And the rest is history.
• 37:37
  Speaker 2: But you know, to his credit, he went and knocked
• 37:39
  Speaker 2: on the Saint Petersburg.
• 37:40
  Speaker 1: Lab and they took him in and he became a
• 37:44
  Speaker 1: protege of Cavinson.
• 37:46
  Speaker 2: So he's really responsible for the first generation of those
• 37:51
  Speaker 2: bioregulators coming to the US now there. You know, obviously
• 37:55
  Speaker 2: with people like you and Phil and others like.
• 38:00
  Speaker 3: Miss our last shipment got seized and sent back.
• 38:04
  Speaker 1: Really yeah, even through Phil because he said he was
• 38:08
  Speaker 1: trying to set up a distribution facility in the US.
• 38:12
  Speaker 3: Yeah, if something works, they're going to try to block it.
• 38:15
  Speaker 2: Oh, that's really sad. I'm sorry sorry to hear that. Okay,
• 38:19
  Speaker 2: So that was like one Tony, do you want to
• 38:21
  Speaker 2: do the next time.
• 38:25
  Speaker 3: Or can you go back? I think there was a famous.
• 38:29
  Speaker 2: Oh okay, let's if he's still here? Are you with us, Tony?
• 38:33
  Speaker 3: I am okay?
• 38:35
  Speaker 2: Can you show I guess I can't want to see
• 38:37
  Speaker 2: that side this real quick?
• 38:40
  Speaker 3: Previous side, previous line. Let's look at this right here?
• 38:44
  Speaker 2: Is it that one?
• 38:46
  Speaker 1: Uh?
• 38:46
  Speaker 2: Yeah?
• 38:47
  Speaker 3: Go one up? One more up?
• 38:49
  Speaker 2: Yeah, the original one you showed, Tony.
• 38:51
  Speaker 4: Okay, let me get that for you and I can
• 38:55
  Speaker 4: edit this out by the way.
• 38:57
  Speaker 2: Yeah, we won't. We won't have it and starts.
• 39:02
  Speaker 3: We're gonna say, oh, I thought there was one in
• 39:04
  Speaker 3: between the outside there was.
• 39:06
  Speaker 1: A graph one that ye, yeah, okay, this is the
• 39:09
  Speaker 1: one you're on.
• 39:11
  Speaker 3: Yeah, good, go ahead, Sorry, it's all right, we can
• 39:14
  Speaker 3: go back to.
• 39:15
  Speaker 2: Oh, let's start, let's go out one.
• 39:18
  Speaker 3: So even the CDC acknowledges that eighty percent of aged
• 39:25
  Speaker 3: adults have at least one chronic illness due to the
• 39:29
  Speaker 3: evolution of the thymus. Why not just give people the
• 39:34
  Speaker 3: needs a month to fix that? And now just think,
• 39:39
  Speaker 3: if you just remove one chronic illness per person, how
• 39:44
  Speaker 3: much would that be worth? Right?
• 39:46
  Speaker 1: But yeah, and billions of dollars of healthcare costs to
• 39:50
  Speaker 1: all of the taxpayers, plus the wellness and the attitudes
• 39:56
  Speaker 1: of healthier people that make a.
• 39:58
  Speaker 2: Much less divisive world, in a happier world.
• 40:01
  Speaker 3: I mean that people, that's a good point. I never
• 40:05
  Speaker 3: thought of that little subtlety there.
• 40:07
  Speaker 2: Yeah, yeah, no, it's true. I mean, you know, when
• 40:10
  Speaker 2: you're sick, you're the world look very.
• 40:13
  Speaker 3: Dark, and oh, you don't want to talk to anyone
• 40:15
  Speaker 3: like you, you don't want.
• 40:16
  Speaker 2: To talk to anyone. You don't want to you know,
• 40:18
  Speaker 2: you're and and then it comes to the whole psychological
• 40:20
  Speaker 2: side of that, you start giving up, like you almost did.
• 40:25
  Speaker 3: Thank you. Yeah, I was gonna off myself. Yeah, yeah,
• 40:28
  Speaker 3: you have.
• 40:28
  Speaker 2: I mean that's pretty that's pretty extreme.
• 40:32
  Speaker 3: Oh, it's horrible. It's you know when people have chronic
• 40:35
  Speaker 3: lime andronic film response, it's it's horrible. No one realizes
• 40:41
  Speaker 3: how freaking bad they feel. People are like, oh, just exercise,
• 40:44
  Speaker 3: eat better. You want to kill them. Yeah, it's horrible,
• 40:48
  Speaker 3: and they they are suffering more than you know.
• 40:51
  Speaker 2: And they always say stress.
• 40:52
  Speaker 4: You know.
• 40:53
  Speaker 2: Oh, it's that's like to catch all.
• 40:54
  Speaker 1: You know, if you're just you're just stressed, you have
• 40:57
  Speaker 1: to go meditate more or whatever.
• 40:59
  Speaker 2: You but you feel like crap.
• 41:03
  Speaker 3: And the people, like in general, people can be empathetic
• 41:07
  Speaker 3: for about two to four weeks and then they're like,
• 41:11
  Speaker 3: come on, get out of bad. You know, it's true,
• 41:14
  Speaker 3: it's tough.
• 41:15
  Speaker 1: So so then so in the bioregulators, there's one called Sime.
• 41:20
  Speaker 2: What's it called.
• 41:20
  Speaker 1: It's a Russian name, but it's it's the bioregula.
• 41:24
  Speaker 3: Yeah, so if you look at what really is the
• 41:27
  Speaker 3: core is the thimus and the pineyer. Yeah, if you
• 41:32
  Speaker 3: want to throw up the slides, and I think it
• 41:34
  Speaker 3: talks about that. But and then if I had to
• 41:36
  Speaker 3: throw another one in there, and I don't Natalie need them,
• 41:39
  Speaker 3: we agree on this is the vascular Yeah, the blood vessel,
• 41:44
  Speaker 3: which will actually reduce the inflammation in the blood vessels.
• 41:49
  Speaker 3: Now you know, as people get older, that basically doesn't
• 41:53
  Speaker 3: work and they get you know, stiff vessels, so they
• 41:56
  Speaker 3: get hypertension. You know, it starts collecting you know, calcium
• 42:00
  Speaker 3: plaque and gets stiff. So it actually reverses that. And
• 42:04
  Speaker 3: it also basically is a cinemorphic, so that all the
• 42:09
  Speaker 3: sas like, all the inflammation it can set down, So
• 42:12
  Speaker 3: it has multiple ways, and it also boosts themselves, so
• 42:18
  Speaker 3: adding that to everything is shown to work better like
• 42:21
  Speaker 3: the studies on for instance, in our cognipep where we
• 42:26
  Speaker 3: have the cortexin the pineleon for the brain, wead the
• 42:32
  Speaker 3: vesugen which is the blood vessel. It just works like
• 42:36
  Speaker 3: four times as well.
• 42:37
  Speaker 2: And so you know, this is really important to go
• 42:40
  Speaker 2: over the conditions that are obviously being addressed by the
• 42:44
  Speaker 2: peptide both peptides and peptide bioregulators. And so I think one.
• 42:49
  Speaker 1: Of the biggest ones in our world today is the
• 42:52
  Speaker 1: microbion and the gut brain access. So would you talk
• 42:55
  Speaker 1: about that for a moment and tell us, you know,
• 42:58
  Speaker 1: what your suggestions are for people who are trying to.
• 43:03
  Speaker 3: The gut is so huge, and we have all these
• 43:06
  Speaker 3: you know, forever chemicals and toxins and pesticides and plastics.
• 43:11
  Speaker 3: It's just glcas just ripping the guts open out and
• 43:16
  Speaker 3: everyone else theaky gut so allergic to everything. All this
• 43:20
  Speaker 3: autoimmunity is just is just going rampant and so it's
• 43:24
  Speaker 3: not so you got to really heal that gut lining.
• 43:27
  Speaker 3: So BPC is key for that. Again, I mentioned that
• 43:31
  Speaker 3: TV four frag will focus on the tight junctions and
• 43:35
  Speaker 3: some people will give like BPC because it's argining BPC,
• 43:40
  Speaker 3: it's stable VPC. They it doesn't absorb very well because
• 43:43
  Speaker 3: it's very polar. They give snack with it, which is
• 43:46
  Speaker 3: a basically increases absorption, which is banned in Europe. And
• 43:51
  Speaker 3: it breaks open the tight junctions. So you're giving something
• 43:54
  Speaker 3: to heal the gut, but you're breaking up the tight junctions.
• 43:57
  Speaker 1: Wow.
• 43:58
  Speaker 2: Oh so that's yeah.
• 44:01
  Speaker 3: And so it's like and they're like, well, it's shown
• 44:04
  Speaker 3: to be safe, but you know it's the government did
• 44:06
  Speaker 3: the study saying healthy people will heal, but they don't
• 44:09
  Speaker 3: have anyone who has chronic illness at all. And then
• 44:13
  Speaker 3: so we have like, uh with gut feeling, which we
• 44:16
  Speaker 3: have the BPC, kpv T before frag acromancia, which is
• 44:21
  Speaker 3: a probiotic associated with health and basically lean muscle and uh,
• 44:28
  Speaker 3: and like we're destroying our microbiome with it with all
• 44:31
  Speaker 3: this stuff too, and there's so many toxins that are
• 44:36
  Speaker 3: additives that just kill the microbiome and so and you
• 44:42
  Speaker 3: look at you know, studies for dementia and heart disease
• 44:46
  Speaker 3: really correlates with with the microbiome. But you have to
• 44:49
  Speaker 3: like BPC will will help heal the microbiome, so you
• 44:52
  Speaker 3: can actually naturally put all these things together. So but
• 44:56
  Speaker 3: I'm really a big fan of you know, basically healing
• 45:00
  Speaker 3: the gut adding you know, all these the key keystone
• 45:06
  Speaker 3: the probiotics where kind of standard probiotics is going they're gone,
• 45:10
  Speaker 3: but you want keystone that basically, and and they have
• 45:14
  Speaker 3: spore based so that they're for a long time and
• 45:17
  Speaker 3: they build that community.
• 45:19
  Speaker 2: Yeah, I think.
• 45:20
  Speaker 1: People forget the most important thing about probiotics is they
• 45:25
  Speaker 1: of them never get to where they's supposed to be
• 45:27
  Speaker 1: because they can't get through the ass the acidic gut barriers.
• 45:32
  Speaker 1: And so you have the spore based at least are
• 45:36
  Speaker 1: are being scientifically shown right to.
• 45:41
  Speaker 3: Its interesting too with acromancia is dead acromancia, we're shown
• 45:45
  Speaker 3: to have better effects than live acromancia. But then you
• 45:50
  Speaker 3: look at you know, downstream, there's not great studies on that.
• 45:53
  Speaker 3: But and so because it shows that it is a
• 45:57
  Speaker 3: receptor mediated phenomena. So if you have acromancia, it attaches
• 46:02
  Speaker 3: to the receptor and has the immune modutory and the
• 46:05
  Speaker 3: gut brain access of modulation. So we add you know, basically,
• 46:11
  Speaker 3: you know, tons of the dead and alive.
• 46:14
  Speaker 1: Yeah, and Adam Kerman was on my podcast. So I
• 46:19
  Speaker 1: buy a lot of.
• 46:20
  Speaker 2: You know, by the only Achamanci I've bought is through Pendulum.
• 46:25
  Speaker 2: So are you familiar with them?
• 46:27
  Speaker 3: Yeah? Yeah, yeah, we talk to them all the time.
• 46:30
  Speaker 2: Yeah, so you use their product as well.
• 46:33
  Speaker 3: Well, we have our own, but I do.
• 46:35
  Speaker 2: I didn't know that.
• 46:36
  Speaker 3: Yeah, well it's in our gut feeling.
• 46:38
  Speaker 1: Yeah, okay, okay, well I should recommend.
• 46:41
  Speaker 2: Okay, well now I know that that's good to know. Well,
• 46:45
  Speaker 2: but chamancia has become the darling of the gut.
• 46:49
  Speaker 3: Yeah, and then you look at you know, a roitery
• 46:54
  Speaker 3: and basically showing for dementia and aging, and there's so
• 47:00
  Speaker 3: many things that this basically bacteria in your gut will
• 47:04
  Speaker 3: prevent X, Y Z. And they're getting so much better
• 47:08
  Speaker 3: at that, you know.
• 47:09
  Speaker 1: So the probably the first thing that people think about
• 47:12
  Speaker 1: it for ailments is the microbios. The second one is
• 47:17
  Speaker 1: obviously Alzheimer's and brain dementia and brain deterioration, so it
• 47:25
  Speaker 1: sometimes morph into Alzheimer's. So doctor Brettison, another one of
• 47:29
  Speaker 1: my prior guests, he says, you know, Alzheimer's is a
• 47:33
  Speaker 1: curable disease.
• 47:35
  Speaker 2: Absolutely, why do you feel that way?
• 47:38
  Speaker 3: What can we seen it? ALS? Curable disease. We have
• 47:43
  Speaker 3: patients coming in and wheelchairs, they're jogging. They go back
• 47:47
  Speaker 3: to the neurologists and then and they say, hey, I'm cured. Like, well,
• 47:53
  Speaker 3: you must not have had ALS because incurable, So it
• 47:56
  Speaker 3: must have been misdiagnosis three of you. Okay, Alzheimer's totally normal.
• 48:03
  Speaker 3: We see it all that time.
• 48:05
  Speaker 1: So what's the protocol for for getting those cubits?
• 48:09
  Speaker 3: Yeah? No, the protocol we we do kitchen sink. But yeah,
• 48:14
  Speaker 3: Preston's part is yes, to do it, but I'm a
• 48:21
  Speaker 3: little ad d for that. I want, you know, action.
• 48:25
  Speaker 3: And for instance, there this doctor, this uh Aos who
• 48:30
  Speaker 3: was a mentor of mine many many years ago as ALS,
• 48:33
  Speaker 3: and I'm like, let me just try to put together
• 48:35
  Speaker 3: our protocol and I'll send it. I'll summarize it for him.
• 48:39
  Speaker 3: I ended up with five hundred slides sending him.
• 48:42
  Speaker 2: Oh wow, so you.
• 48:45
  Speaker 3: Had to show you, Like, what's the protocol? Al right,
• 48:46
  Speaker 3: People like, what's your line protocol? Yeah, like that's a
• 48:50
  Speaker 3: thousands lines. But yeah, and but it's where we're trying
• 48:55
  Speaker 3: to develop the uh Basically, the algorithm of protocols, so
• 49:00
  Speaker 3: because uh so, so many doctors can do it instead
• 49:03
  Speaker 3: of by giving them this little bit, this little bit. Yeah, basically,
• 49:07
  Speaker 3: our model for our center was I would train doctors
• 49:09
  Speaker 3: for two years, then we could treat anything. Really, anything
• 49:12
  Speaker 3: came to the door, I'm telling you. But I can't
• 49:15
  Speaker 3: get doctors to do it anymore. They're just they don't
• 49:17
  Speaker 3: want to spend the time. They don't seem to understand concepts,
• 49:22
  Speaker 3: they want to memorize, they want an algorithm, you know,
• 49:25
  Speaker 3: they want to leave from nine to five. I just
• 49:27
  Speaker 3: I don't. It's it's a different world, I guess. So
• 49:30
  Speaker 3: I'm starting to realize that. So I hate I've always
• 49:34
  Speaker 3: hated protocols because I'm like everyone's individual. But that's true
• 49:38
  Speaker 3: love protocols. Doctors love protocols. So I think maybe it's
• 49:43
  Speaker 3: not totally perfect and not optimal in the in this
• 49:47
  Speaker 3: you know, fantasy world. But I'm going to just do
• 49:50
  Speaker 3: protocols for everything and it's going to be eighty percent
• 49:54
  Speaker 3: you know, as good. But we can treat so many more.
• 49:57
  Speaker 1: Patients, right, I mean, in a protoc call two, it's
• 50:00
  Speaker 1: a baseline that you.
• 50:02
  Speaker 3: Can build, you know what. That won't make me sleep
• 50:05
  Speaker 3: at night.
• 50:05
  Speaker 2: Yeah, exactly, no, true, And it's just like the BPC.
• 50:10
  Speaker 1: I mean you're starting there because you know that has
• 50:14
  Speaker 1: this impact, this efficacy, but then you're stacking with these
• 50:18
  Speaker 1: other pep ties or peptide bioregulars that are going to
• 50:24
  Speaker 1: be specific, customized to that particular patience.
• 50:28
  Speaker 3: I really like that. Now I can live with myself.
• 50:34
  Speaker 3: So I'm always like, God, Debby, you got to be like,
• 50:36
  Speaker 3: you know, custom, totally custom. But if you can help
• 50:40
  Speaker 3: ten times more patients and be semi custom, probably a
• 50:44
  Speaker 3: good thing.
• 50:44
  Speaker 2: Right, Absolutely, that's what it's missing.
• 50:47
  Speaker 1: I think in most in the allopathic practice, as a
• 50:52
  Speaker 1: customized approach, it's sort of a one size fits all.
• 50:56
  Speaker 3: I have to thank you, I feel better.
• 50:59
  Speaker 1: Well, you know, they reach into their pocket, let me
• 51:01
  Speaker 1: give you a prescription for X y Z, and then
• 51:04
  Speaker 1: you're gone.
• 51:05
  Speaker 2: And you know, now you have all these side effects.
• 51:08
  Speaker 3: And I'm sure you've seen it's like care is so
• 51:11
  Speaker 3: fricking barbaric. Yeah, I mean for diabetes, they're just like,
• 51:16
  Speaker 3: I don't treat it on the heart disease, or or
• 51:19
  Speaker 3: they like, well okay, yeah you may have a strug,
• 51:21
  Speaker 3: we'll wait till you have a stroke and then we'll
• 51:23
  Speaker 3: treat it like yes, I.
• 51:25
  Speaker 1: Know, so before we get cut off because the time
• 51:28
  Speaker 1: is running out, and I know we didn't get through
• 51:30
  Speaker 1: all your slides, but.
• 51:31
  Speaker 3: I apologize, no worries, no worries.
• 51:33
  Speaker 1: I knew this would happen because you have so much
• 51:36
  Speaker 1: knowledge and there's so much to talk about. But before
• 51:40
  Speaker 1: we leave, we have to talk about the semi glue
• 51:42
  Speaker 1: ties because you know, they've become such a big thing
• 51:46
  Speaker 1: and there's so much pro and con.
• 51:48
  Speaker 2: What what's your position on GLP one?
• 51:52
  Speaker 3: You know, I think they're great. But anytime you try
• 51:56
  Speaker 3: to extrapolate a drug of medication that you know, for
• 52:01
  Speaker 3: let's say for diabetes, now, oh it's for everyone, let's
• 52:04
  Speaker 3: put in the water, you're going to side effects. You
• 52:06
  Speaker 3: are gonna have negative outcomes. And then people are just like,
• 52:10
  Speaker 3: oh my god, it's you know, it's the magic thing
• 52:13
  Speaker 3: and it's gonna exponentially increase side effects. So it's like yeah,
• 52:19
  Speaker 3: and we always try to think, oh this is good,
• 52:22
  Speaker 3: this is bad, and even like I always think about
• 52:26
  Speaker 3: people are doing all this aesthetic procedures, right, they think
• 52:29
  Speaker 3: there's no downside. So many bad things happen with that
• 52:34
  Speaker 3: and they don't realize there's a downside. There's a downside
• 52:37
  Speaker 3: to all these GLP ones in the right selected patients
• 52:42
  Speaker 3: exceedingly safe and that low dose if you if you
• 52:46
  Speaker 3: stick to low dose, great benefits for reducing dementia and
• 52:50
  Speaker 3: depression and metabolic health and all that. Now you start
• 52:55
  Speaker 3: ramping it for I want twenty pounds and thirty pounds
• 52:58
  Speaker 3: of weight loss a month, you're gonna have issues, you.
• 53:00
  Speaker 2: Know, exactly.
• 53:01
  Speaker 1: Yeah, So Elizabeth Earth, doctor Earth from the Yeah, so
• 53:06
  Speaker 1: she said, two years ago, I think she lived my guest.
• 53:10
  Speaker 1: And she said, you know, she even uses them, but
• 53:13
  Speaker 1: she doesn't need to lose weight, but she does it
• 53:15
  Speaker 1: for those other benefits as well as, you know, just
• 53:20
  Speaker 1: keeping her her weight and control.
• 53:23
  Speaker 2: And she said she microdoses.
• 53:26
  Speaker 3: So that that is gonna basically shown to be the
• 53:30
  Speaker 3: way to do it has so many more benefits. The
• 53:32
  Speaker 3: risk benefit is dramatically or the benefit risk dramatically increased.
• 53:38
  Speaker 3: That Lodo says, you go up, it starts reducing.
• 53:41
  Speaker 1: Yeah, and then and then combine it with dipper Morell
• 53:44
  Speaker 1: and Ippen Morell and because of the scarclopinia, So can
• 53:48
  Speaker 1: you talk about.
• 53:48
  Speaker 3: That for a moment, Uh, you know, we're uh just
• 53:52
  Speaker 3: put out is the gop ones and full of statin. Oh,
• 53:58
  Speaker 3: you know, full of statins. Yeah. So when your body
• 54:02
  Speaker 3: is actually older or stressed or inflamed, your body makes myostatin.
• 54:08
  Speaker 3: So myostatin keeps your body from losing weight, losing fat,
• 54:13
  Speaker 3: or gaining lean muscle.
• 54:14
  Speaker 2: Yeah.
• 54:14
  Speaker 3: So the follostatin blocks the blocker blocks the myostatin. So
• 54:20
  Speaker 3: it is I can't believe people aren't abusing. Actually bodybuilders are,
• 54:25
  Speaker 3: but probably ten times as potent as a steroid, and
• 54:29
  Speaker 3: it's good for you.
• 54:30
  Speaker 2: It won't have side effects.
• 54:32
  Speaker 3: Well everything is side effects, so I can't see that.
• 54:34
  Speaker 3: I'm just saying in general, all the things that it
• 54:37
  Speaker 3: does are reduces inflammation, is actually you know, increases or
• 54:44
  Speaker 3: tuins in that and shown to be exceedingly safe because
• 54:49
  Speaker 3: like the you can do ten times a dose, but
• 54:51
  Speaker 3: you don't need ten times a dose, so not only
• 54:54
  Speaker 3: keep your lean muscle, you'll gain lean muscle if you
• 54:57
  Speaker 3: work out even better, but you don't have to. And
• 55:01
  Speaker 3: then you add the g O P one. Now you're
• 55:04
  Speaker 3: losing body fat, and you combine the body fat loss,
• 55:07
  Speaker 3: which people they lose all you know, muscle and fat
• 55:10
  Speaker 3: and which yeah, and which also I want to bring
• 55:17
  Speaker 3: up is that if you diet more than three cycles,
• 55:21
  Speaker 3: and these studies by uh uh Lyle and others that
• 55:26
  Speaker 3: if you have more than three cycles, your metabolism drops,
• 55:29
  Speaker 3: your thyroid level drops, your it's a hypothiine pituitary uh
• 55:34
  Speaker 3: TSH access, so the TSH drops, So it looks you
• 55:38
  Speaker 3: don't know your low thyroid drops, your metabolism drops, and
• 55:43
  Speaker 3: your body it tells the body to store fat. And
• 55:47
  Speaker 3: if you even go back to normal eating, it doesn't
• 55:49
  Speaker 3: go back to normal. So when people say of requine metabolism,
• 55:54
  Speaker 3: they have. And so we'll check people because the blood test,
• 55:59
  Speaker 3: well we can pick it out, but the standard blood
• 56:01
  Speaker 3: test will say, oh, it looks fine, just fine. People
• 56:04
  Speaker 3: are like, my god, I can't lose weight. I'm cold,
• 56:07
  Speaker 3: my hands are cold. I know you. But and then
• 56:10
  Speaker 3: we'll check their base of metabolic grade, how many hours
• 56:13
  Speaker 3: they burn per day. They're generally twenty five percent lower
• 56:16
  Speaker 3: than someone their same age and body weight, so they're
• 56:21
  Speaker 3: like equal to someone who's you know, basically fifty percent
• 56:24
  Speaker 3: less less weight. They have no metabolism unless you give
• 56:30
  Speaker 3: something to boost that, which is generally T three teethe
• 56:35
  Speaker 3: thired or mitochondril boosters can also work, or the thyroid bioregulator,
• 56:40
  Speaker 3: the thyrodactors b irregulator. That it's so hard to lose
• 56:43
  Speaker 3: weight because the more weight you lose, the lower your
• 56:46
  Speaker 3: metabolism goes, and so you can never catch up. So
• 56:50
  Speaker 3: people say, I would say seventy percent plus of people
• 56:56
  Speaker 3: have low thyroid. Their doctor says they are fine, Right,
• 57:01
  Speaker 3: it's problems.
• 57:02
  Speaker 1: Yeah, it's one of the most underdiagnosed conditions in our country,
• 57:07
  Speaker 1: I think, and probably.
• 57:08
  Speaker 2: In the world.
• 57:09
  Speaker 1: But at least here we know that because they do
• 57:11
  Speaker 1: it by the blood work and then they don't do
• 57:14
  Speaker 1: the full complement of testing. They only do the TSH
• 57:17
  Speaker 1: or you know, then they're not really looking.
• 57:20
  Speaker 2: They look for T four.
• 57:21
  Speaker 1: As to give you synthroid or something instead of the
• 57:25
  Speaker 1: T three, which really is going to help you to.
• 57:28
  Speaker 3: Have you know what, and they don't understand physiology and
• 57:32
  Speaker 3: what happens. As you get more inflamed, you get older,
• 57:35
  Speaker 3: you get sicker, the TSH drops and the test goes up. Right,
• 57:40
  Speaker 3: So that is a marker for hythi ride for doctors,
• 57:44
  Speaker 3: not knowing doctors. But the TSH drops because of the inflammation,
• 57:50
  Speaker 3: and then the T four basically goes up because the body,
• 57:54
  Speaker 3: the mitochondrire dysfunction because almost every endophrenologist thinks that whatever
• 58:00
  Speaker 3: thyroid's in the blood diffuses into the cell doesn't happen
• 58:03
  Speaker 3: at all active transport, so it requires energy, and the
• 58:07
  Speaker 3: T four transporter actually requires more energy than T three.
• 58:11
  Speaker 3: So the T four transporter, it basically doesn't work because
• 58:15
  Speaker 3: it needs energy. So the T four goes up in
• 58:18
  Speaker 3: the seerum because it's not getting into blood. So you
• 58:20
  Speaker 3: have low tsa high T four and the oh thyroid,
• 58:23
  Speaker 3: Oh my god, it's the wrong thing. It's and then
• 58:27
  Speaker 3: their free T three is super low and their versity
• 58:29
  Speaker 3: three is high, and you give them thyroid and their
• 58:31
  Speaker 3: life changes.
• 58:32
  Speaker 2: Yeah, exactly. Yeah.
• 58:35
  Speaker 1: So okay, before we have to go, you've been so
• 58:39
  Speaker 1: generous to offer to let our viewers have an opportunity
• 58:45
  Speaker 1: with a discount to try some of the.
• 58:47
  Speaker 2: Integrated peptide products.
• 58:49
  Speaker 1: So why don't you tell us how people could reach
• 58:52
  Speaker 1: you and what that offer is and what the code
• 58:54
  Speaker 1: is that they need to use.
• 58:56
  Speaker 3: Yeah, sure I have some pull over there somehow, but
• 59:01
  Speaker 3: I guess so I was told twenty percent off IP
• 59:03
  Speaker 3: products if you go to Integrative Peptides dot com that's what.
• 59:10
  Speaker 2: That's what an s peptides.
• 59:13
  Speaker 3: Thank you. I'm kind of slurring the silly fast eat uh.
• 59:18
  Speaker 3: And then you plug in ageless twenty yeah you, and
• 59:24
  Speaker 3: you'll get twenty percent off your your first order and
• 59:27
  Speaker 3: we'll ask questions and yeah that.
• 59:31
  Speaker 1: Yeah, yeah, and and can they is it www dot
• 59:34
  Speaker 1: Integrative peptides dot com?
• 59:37
  Speaker 3: Yeah, telling me, I guess they just got up to
• 59:42
  Speaker 3: twenty five percent. Oh wow, you know they plug in
• 59:47
  Speaker 3: ages twenty five or ages twenty Hey, ages twenty. People
• 59:52
  Speaker 3: that stayed on for they just got the twenty but
• 59:54
  Speaker 3: they hung up. Yeah, they don't get twenty five.
• 59:59
  Speaker 2: Oh well, too bad. No, but we'll have it in
• 1:00:02
  Speaker 2: the show notes. So and then they can get your ebook.
• 1:00:06
  Speaker 1: You wrote an e book on peptides, which I think
• 1:00:08
  Speaker 1: people should everybody should read that.
• 1:00:11
  Speaker 3: Yeah, it's so the Peptide Protocol for the rapid treatment
• 1:00:15
  Speaker 3: of sears. Most people don't have serious chronic if I'm
• 1:00:17
  Speaker 3: a response syndrome, but there's so many people with chronic illness,
• 1:00:21
  Speaker 3: and we're coming out with a new version and in
• 1:00:24
  Speaker 3: adding the bioregulars aren't in there. Someone stole off my
• 1:00:28
  Speaker 3: desk and published it. Honestly did I never finish anything right.
• 1:00:32
  Speaker 3: Everything I keep wanting to add add so I have
• 1:00:34
  Speaker 3: like ten books that are ninety percent done. I'm glad
• 1:00:38
  Speaker 3: you did, but we're working. They get that where on
• 1:00:46
  Speaker 3: your on her site? Yes, yeah, I think I suld
• 1:00:49
  Speaker 3: well somehow send it, send it to.
• 1:00:51
  Speaker 1: Us and we'll get it into the show notes. Okay,
• 1:00:54
  Speaker 1: well can't. As you can see, we could have gone
• 1:00:57
  Speaker 1: on for two more hours easily and had still not run.
• 1:01:00
  Speaker 2: Out of the subjects to talk about. There's so much
• 1:01:02
  Speaker 2: that we.
• 1:01:04
  Speaker 1: Want to cover, but I think we got the highlights
• 1:01:06
  Speaker 1: and the things that people are at least the most
• 1:01:09
  Speaker 1: frequent chronic illnesses that people are are addressing in their lives,
• 1:01:15
  Speaker 1: and of course there's so many others.
• 1:01:16
  Speaker 2: But this was a big help.
• 1:01:19
  Speaker 1: And also the other thing that you did today, which
• 1:01:23
  Speaker 1: distinguished between bioregulators and regular peptides, which I think people
• 1:01:28
  Speaker 1: get confused about. So thank you for clarifying that for everybody.
• 1:01:33
  Speaker 3: Awesome And I think I assume I'll see you at
• 1:01:36
  Speaker 3: Radfest and yeah, you.
• 1:01:38
  Speaker 1: Know, I'm going to go to this new one in
• 1:01:39
  Speaker 1: Chicago called Biohackers World. It's brand new, well it's not new,
• 1:01:44
  Speaker 1: but it's new to Chicago. So I'm not sure about
• 1:01:47
  Speaker 1: Radfest because I just I get back, like right as
• 1:01:49
  Speaker 1: Radfest is about to begin.
• 1:01:51
  Speaker 3: Well, I thought you were the Radfest queen there, not
• 1:01:55
  Speaker 3: at all.
• 1:01:56
  Speaker 1: I just had James Stroll on my podcast and he
• 1:01:59
  Speaker 1: invited me last year to come and join them. So
• 1:02:02
  Speaker 1: uh no, I that was my first time ever to
• 1:02:05
  Speaker 1: attend the But but Bill Andrews has been on and
• 1:02:10
  Speaker 1: James and Jim Lavalley, you know all the guys that
• 1:02:13
  Speaker 1: are active in that group.
• 1:02:15
  Speaker 2: So so I may not see you there, but I'll
• 1:02:18
  Speaker 2: see you at eight four a m.
• 1:02:19
  Speaker 3: Sounds good in December. So thanks so much. Keep up
• 1:02:23
  Speaker 3: the wonderful work.
• 1:02:24
  Speaker 2: Oh thank you. It's really important to me what we're doing.
• 1:02:27
  Speaker 1: And now this Top Doctor magazine, the monthly column I'm
• 1:02:31
  Speaker 1: doing is adding to the the protocol of being able
• 1:02:36
  Speaker 1: to help reach reach out to more people to bring information.
• 1:02:39
  Speaker 2: Like today, Yeah, you want to order that product from you?
• 1:02:44
  Speaker 2: I think that what you're called again, and of the
• 1:02:47
  Speaker 2: f when you just talked.
• 1:02:48
  Speaker 3: About the.
• 1:02:51
  Speaker 2: Full stat full of stat, I was going to say
• 1:02:54
  Speaker 2: full Stata.
• 1:02:56
  Speaker 3: Combine that with the Ozembak, It's it's incredible.
• 1:03:02
  Speaker 1: Yeah, So I'm getting Jays sending me just as a
• 1:03:04
  Speaker 1: nice little gift. Not that I needed to lose weight,
• 1:03:07
  Speaker 1: but I like to get you know, stay metabolically strong.
• 1:03:12
  Speaker 1: It's sending me the reality, true reality, true tide.
• 1:03:16
  Speaker 3: That's just it's the upgraded.
• 1:03:19
  Speaker 2: Yeah.
• 1:03:21
  Speaker 3: So it works on another receptor.
• 1:03:23
  Speaker 1: Yeah, yeah, that's what I'm reading. And it's it's not
• 1:03:26
  Speaker 1: nearly as many side effects if you're microdos that I heard,
• 1:03:31
  Speaker 1: so all right, can't well, thank you so much. I'll
• 1:03:33
  Speaker 1: see you in a couple of months, three months or
• 1:03:35
  Speaker 1: four months, like well, it's say June, where are we December.
• 1:03:38
  Speaker 2: I'll see you in December.
• 1:03:40
  Speaker 3: I know it. We'll go by faith so much too.
• 1:03:43
  Speaker 2: Okay, thank you